Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Bal Pharma submitted anti-dumping investigation for China's Gliclazide
>> article
Bal Pharma submitted anti-dumping investigation for China's Gliclazide
Editor:bianch Clicks:
0
Date:2014-4-14 11:50:28
Keyword:
anti-dumping investigation
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Inida started sunset review of anti-dumping duty on metronidazole from...
India's Finance Ministry didn't agree anti-dumping duties for ...
Brazil started antidumping investigation to China's citric acid
Indian BDMA against proposed anti-dumping duty on Pen G, 6-APA
Commerce Ministry reminds anti-dumping duty may be extended
Industry investigation reprot of Vitamin D2 and D3 in China
Indian files anti-dumping investigation for China's Coumarin
Antidumping investigation won't influence Penicillin G export
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
